272 related articles for article (PubMed ID: 21336557)
1. Pathogenesis of ANCA-associated vasculitis, an update.
Kallenberg CG
Clin Rev Allergy Immunol; 2011 Oct; 41(2):224-31. PubMed ID: 21336557
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of ANCA-associated vasculitides.
Kallenberg CG
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i59-63. PubMed ID: 21339221
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of ANCA-associated small vessel vasculitis.
Kallenberg CG
Curr Rheumatol Rep; 2010 Dec; 12(6):399-405. PubMed ID: 20878509
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.
Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
Am J Kidney Dis; 2013 Dec; 62(6):1176-87. PubMed ID: 23810690
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
Kim SM; Choi SY; Kim SY; Kim J
Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
[TBL] [Abstract][Full Text] [Related]
7. New advances in the pathogenesis of ANCA-associated vasculitides.
Chen M; Kallenberg CG
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
[TBL] [Abstract][Full Text] [Related]
8. Emerging concepts in the pathogenesis of antineutrophil cytoplasmic antibody-associated vasculitis.
Flint SM; McKinney EF; Smith KG
Curr Opin Rheumatol; 2015 Mar; 27(2):197-203. PubMed ID: 25629443
[TBL] [Abstract][Full Text] [Related]
9. Lessons from a double-transgenic neutrophil approach to induce antiproteinase 3 antibody-mediated vasculitis in mice.
Schreiber A; Eulenberg-Gustavus C; Bergmann A; Jerke U; Kettritz R
J Leukoc Biol; 2016 Dec; 100(6):1443-1452. PubMed ID: 27365530
[TBL] [Abstract][Full Text] [Related]
10. Genetic loci of Staphylococcus aureus associated with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides.
Glasner C; de Goffau MC; van Timmeren MM; Schulze ML; Jansen B; Tavakol M; van Wamel WJB; Stegeman CA; Kallenberg CGM; Arends JP; Rossen JW; Heeringa P; van Dijl JM
Sci Rep; 2017 Sep; 7(1):12211. PubMed ID: 28939882
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.
Savage CO
Clin Exp Immunol; 2011 May; 164 Suppl 1(Suppl 1):23-6. PubMed ID: 21447127
[TBL] [Abstract][Full Text] [Related]
12. Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge.
Bonaci-Nikolic B; Andrejevic S; Pavlovic M; Dimcic Z; Ivanovic B; Nikolic M
Clin Rheumatol; 2010 Aug; 29(8):893-904. PubMed ID: 20306213
[TBL] [Abstract][Full Text] [Related]
13. An unusual presentation of propylthiouracil-induced anti-MPO and PR3 positive ANCA vasculitis with associated anti-GBM antibodies, IgA nephropathy and an IgG4 interstitial infiltrate: a case report.
Galante JR; Daruwalla CP; Roberts ISD; Haynes R; Storey BC; Bottomley MJ
BMC Nephrol; 2020 Jul; 21(1):295. PubMed ID: 32703233
[TBL] [Abstract][Full Text] [Related]
14. Complement activation in pauci-immune necrotizing and crescentic glomerulonephritis: results of a proteomic analysis.
Sethi S; Zand L; De Vriese AS; Specks U; Vrana JA; Kanwar S; Kurtin P; Theis JD; Angioi A; Cornell L; Fervenza FC
Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i139-i145. PubMed ID: 28391334
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil Gelatinase-Associated Lipocalin Protects from ANCA-Induced GN by Inhibiting T
Schreiber A; Rousselle A; Klocke J; Bachmann S; Popovic S; Bontscho J; Schmidt-Ott KM; Siffrin V; Jerke U; Ashraf MI; Panzer U; Kettritz R
J Am Soc Nephrol; 2020 Jul; 31(7):1569-1584. PubMed ID: 32487561
[TBL] [Abstract][Full Text] [Related]
16. Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.
Murosaki T; Sato T; Akiyama Y; Nagatani K; Minota S
Mod Rheumatol; 2017 Jan; 27(1):95-101. PubMed ID: 27320904
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis.
Bornstein G; Ben-Zvi I; Furie N; Grossman C
Int J Rheum Dis; 2019 May; 22(5):940-945. PubMed ID: 30729688
[TBL] [Abstract][Full Text] [Related]
18. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.
Xiao H; Schreiber A; Heeringa P; Falk RJ; Jennette JC
Am J Pathol; 2007 Jan; 170(1):52-64. PubMed ID: 17200182
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
Csernok E; Lamprecht P; Gross WL
Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014.
Schönermarck U; Csernok E; Gross WL
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i46-52. PubMed ID: 25540095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
